Digitalis comes from the foxglove plant, a tall flowering species native to Europe that has been used in heart medicine for over two centuries. The two most important species are Digitalis purpurea (common foxglove) and Digitalis lanata (woolly foxglove), both of which produce powerful compounds called cardiac glycosides in their leaves. Even today, the pharmaceutical drug digoxin is still extracted from dried foxglove leaves rather than made synthetically in a lab.
The Foxglove Plant
Common foxglove is a biennial, meaning it takes two years to complete its life cycle. In the first year, it produces only a low rosette of velvety, oval leaves close to the ground. In the second year, a tall flower spike shoots up bearing dozens of tubular, bell-shaped blooms that hang downward along one side of the stem. The flowers are 2 to 3 inches long and range from deep purple to pale pink, white, and occasionally yellowish, with distinctive spotted markings inside the petals. The plant thrives in partially shaded woodland edges, rocky slopes, and disturbed soils across western and central Europe, though it has naturalized widely in North America, parts of South America, and the Pacific Northwest.
Digitalis lanata, the woolly foxglove, is native to southeastern Europe and is less commonly grown in gardens. It produces smaller, cream-colored flowers with brownish veining. Despite being less showy, this species is the primary commercial source of digoxin because its leaves contain higher concentrations of that specific compound.
What the Plant Actually Produces
Foxglove leaves contain a family of chemicals called cardiac glycosides, which share a common molecular structure: a steroid ring, a lactone ring, and a sugar molecule. The most medically significant of these compounds are digitoxin (from D. purpurea) and digoxin (from D. lanata). Both affect the heart in similar ways, but digoxin became the standard pharmaceutical drug because the body clears it more predictably.
The highest concentrations of these compounds sit in the leaves, though every part of the plant is toxic. Analysis of dried D. purpurea leaf powder has identified multiple glycosides present simultaneously, including digitoxin, gitoxin, and gitaloxin. This cocktail of related chemicals is why raw foxglove is dangerously unpredictable compared to a purified pharmaceutical dose.
How Foxglove Became Heart Medicine
The connection between foxglove and heart treatment traces back to an English physician named William Withering, who published his landmark account of the plant’s medical effects in 1785. Withering had learned about foxglove from a local herbalist whose folk remedy for “dropsy” (the old term for fluid buildup caused by heart failure) included the plant among its ingredients. He spent roughly a decade carefully documenting its effects on patients, recording both successful treatments and cases of poisoning.
Interestingly, Withering himself didn’t fully understand why foxglove worked. He believed it acted primarily on the kidneys because patients urinated more and lost their excess fluid. The drug’s direct effect on the heart, strengthening its contractions, wasn’t recognized until later. Still, his meticulous records of dosing and side effects laid the groundwork for digitalis becoming one of the most important drugs in cardiology.
How It Works in the Body
Digitalis compounds strengthen the heart by interfering with a molecular pump on the surface of heart muscle cells. This pump normally moves sodium out of cells and potassium in. When digitalis blocks it, sodium builds up inside the cell, which triggers a chain reaction that increases the amount of calcium available for muscle contraction. The result is a stronger heartbeat with each squeeze, which helps a failing heart push blood more effectively. Digitalis also slows the heart rate, making it useful for conditions where the heart beats too fast or irregularly.
From Garden Plant to Pharmacy Shelf
Digoxin was first isolated from Digitalis lanata in 1930 by Dr. Sydney Smith, but it wasn’t approved by the FDA until the late 1990s. Even with modern chemistry, digoxin continues to be derived from actual foxglove plants through an extraction process that starts with dried leaves and purifies the compound to pharmaceutical grade. Total chemical synthesis is possible but not commercially practical, so foxglove farming remains part of the drug’s supply chain.
One reason digoxin requires such careful dosing is its extremely narrow therapeutic window. Blood levels need to stay between roughly 0.5 and 1.0 nanograms per milliliter for heart failure patients. Levels above 2.0 ng/mL raise the risk of toxicity, and concentrations at or above 1.2 ng/mL have been linked to increased mortality. That’s a remarkably thin margin between helpful and harmful, which is why patients on digoxin need regular blood monitoring. The difference between a therapeutic dose and a toxic one can come down to small changes in kidney function, hydration, or interactions with other medications.
Why Foxglove Is Dangerous Outside a Pharmacy
Because foxglove is a popular garden plant, accidental poisonings still happen. Every part of the plant contains cardiac glycosides, from the flowers and leaves down to the roots and seeds. Even the water in a vase of cut foxglove can contain enough toxin to cause problems. Symptoms of poisoning include nausea, vomiting, visual disturbances (classically seeing yellow halos around lights), dangerously slow or irregular heartbeat, and in severe cases, cardiac arrest.
The unpredictability of the raw plant is exactly why Withering spent years trying to standardize his doses in the 1780s. Glycoside concentrations vary depending on the species, the time of year the leaves are harvested, growing conditions, and how the leaves are dried. A single leaf from one plant might contain a very different amount of active compound than a leaf from the plant next to it. This variability is what makes eating any part of foxglove so dangerous, and why the purified pharmaceutical version exists.